BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 7544838)

  • 1. A case of acute pancreatitis and enterocutaneous fistula formation following extended right hemicolectomy.
    Kay TJ; Gallagher PJ
    J Surg Case Rep; 2023 Mar; 2023(3):rjad122. PubMed ID: 36942291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retroperitoneal lymph node dissection for residual masses after chemotherapy in nonseminomatous germ cell testicular tumor.
    Luz MA; Kotb AF; Aldousari S; Brimo F; Tanguay S; Kassouf W; Aprikian AG
    World J Surg Oncol; 2010 Nov; 8():97. PubMed ID: 21062470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nerve sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer.
    Coogan CL; Hejase MJ; Wahle GR; Foster RS; Rowland RG; Bihrle R; Donohue JP
    J Urol; 1996 Nov; 156(5):1656-8. PubMed ID: 8863564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjunctive nephrectomy at post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer.
    Stephenson AJ; Tal R; Sheinfeld J
    J Urol; 2006 Nov; 176(5):1996-9; discussion 1999. PubMed ID: 17070234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity?
    Mosharafa AA; Foster RS; Leibovich BC; Bihrle R; Johnson C; Donohue JP
    J Urol; 2003 Jun; 169(6):2126-8. PubMed ID: 12771733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroperitoneal lymph node dissection in patients with high risk testicular cancer.
    Williams SB; McDermott DW; Dock W; Bahnson E; Berry AM; Steele GS; Richie JP
    J Urol; 2009 May; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence pattern and proposed surveillance protocol following post-chemotherapy retroperitoneal lymph node dissection.
    Spiess PE; Brown GA; Liu P; Tu SM; Tannir NM; Evans JG; Kamat AM; Kassouf W; Pisters LL
    J Urol; 2007 Jan; 177(1):131-8. PubMed ID: 17162023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperamylasemia after post-chemotherapy retroperitoneal lymph node dissection for testis cancer.
    Baniel J; Leibovitch I; Foster RS; Rowland RG; Bihrle R; Donohue JP
    J Urol; 1995 Oct; 154(4):1373-5. PubMed ID: 7544838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroperitoneal lymph node dissection for the management of clinical stage I nonseminoma.
    Foster RS; Donohue JP
    J Urol; 2000 Jun; 163(6):1788-92. PubMed ID: 10799183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postchemotherapy retroperitoneal lymph node dissection for testis cancer.
    Risk MC; Foster RS
    Expert Rev Anticancer Ther; 2011 Jan; 11(1):95-106. PubMed ID: 21166514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle.
    Yoon GH; Stein JP; Skinner DG
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):75-85. PubMed ID: 15757440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ cell tumors: long-term oncologic outcomes.
    Finelli A
    Curr Opin Urol; 2008 Mar; 18(2):180-4. PubMed ID: 18303540
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.